bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.04.15.647522

Toward Unified Biomarkers for Focal Epilepsy

Abstract

Accurately localizing the epileptogenic network (EpiNet) remains a major barrier to effective epilepsy treatment, largely due to limited mechanistic understanding. The EpiNet is a patient-specific brain network shaped by complex, overlapping pathology. While combining biomarkers can improve localization, it also generates high-dimensional feature data that increases the risk of overfitting and reduces interpretability. We hypothesized that the core epileptogenic dynamics could be captured in a low-dimensional latent space derived from empirical data, without the need to record seizures. From interictal stereo-EEG (SEEG) recordings in 64 patients (29 females), we extracted 260 neuronal features and reduced them to 10 latent components using singular value decomposition. A classifier trained on these 10 components was then simplified into a probabilistic EpiNet model requiring only two components as input. Individual position in this two-dimensional latent space correlated with previously reported classification accuracy (r2=0.5), supporting its functional relevance. In three independent patients, the probabilistic model captured time-varying epileptogenic dynamics during sleep-SEEG recordings, corroborated clinical assessments, and achieved peak classification accuracies of 0.63, 0.85, and 0.94. These predictions were independently validated by tensor component analysis. Together, these results provide evidence for a robust low-dimensional representation of epileptogenicity across brain states and pathological substrates. This approach simplifies interpretation, facilitates integration of additional biomarkers, and enables large-scale cohort analyses, establishing a proof of concept for a unified framework for epilepsy biomarkers. Significance StatementTo advance mechanistic understanding of large-scale brain dynamics underlying epilepsy, we combined novel epilepsy biomarkers with interpretable machine learning. From interictal SEEG, we extracted 260 connectivity and criticality features. Dimensionality reduction of these raw features showed that only two components were needed to identify epileptogenic networks, reducing the feature space by >99%. These components were highlighted by abnormal power-law scaling, bistability, and strong inhibition or excitation in the 15-200 Hz range, consistent with prior findings. The model tracked neuropathological dynamics over hours and was validated through tensor component analysis, suggesting that epileptogenic activity is dynamic, subject-specific, and sparsely represented in both state space and cortical networks.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Wang, S. H., Ferrari, P., Arnulfo, G., Marzulli, M., Degras, D., Myrov, V., Palva, S., Nobili, L., Ciuciu, P., Palva, M.. 2025-04-20. Toward Unified Biomarkers for Focal Epilepsy. https://doi.org/10.1101/2025.04.15.647522

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗